Paul Cuddon
Stock Analyst at Deutsche Bank
(3.38)
# 2,347
Out of 4,534 analysts
25
Total ratings
55.6%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Paul Cuddon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 210p → 225p | 113p | +99.47% | 6 | Jan 22, 2026 | |
| LON: SYNC Syncona Limited | Maintained: Buy | 170p | 106p | n/a | 1 | Jun 20, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Maintained: Buy | 2,750p → 3,100p | 1,542p | n/a | 3 | Nov 25, 2024 | |
| INDV Indivior Pharmaceuticals | Maintained: Buy | $20 → $17 | $40.54 | n/a | 4 | Oct 11, 2024 | |
| MXCT MaxCyte | Upgraded: Buy | $4.44 → $6.73 | $1.24 | n/a | 2 | Oct 10, 2024 | |
| LON: OXB Oxford Biomedica plc | Maintained: Hold | 250p → 380p | 632p | n/a | 2 | Sep 24, 2024 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 310p | 387p | n/a | 2 | Sep 4, 2024 | |
| AIM: AVCT Avacta Group Plc | Initiated Coverage: Hold | 40p | 70p | n/a | 2 | Jun 19, 2024 | |
| AIM: NIOX NIOX Group Plc | Initiated Coverage: Hold | 250p | 60p | n/a | 1 | May 3, 2024 | |
| AIM: CREO Creo Medical Group PLC | Maintained: Buy | 80p | 14p | n/a | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 100p | 66p | n/a | 1 | May 3, 2024 |
Oxford Nanopore Technologies plc
Jan 22, 2026
Reiterated: Buy
Price Target: 210p → 225p
Current: 113p
Upside: +99.47%
Syncona Limited
Jun 20, 2025
Maintained: Buy
Price Target: 170p
Current: 106p
Upside: n/a
Hikma Pharmaceuticals PLC
Nov 25, 2024
Maintained: Buy
Price Target: 2,750p → 3,100p
Current: 1,542p
Upside: n/a
Indivior Pharmaceuticals
Oct 11, 2024
Maintained: Buy
Price Target: $20 → $17
Current: $40.54
Upside: n/a
MaxCyte
Oct 10, 2024
Upgraded: Buy
Price Target: $4.44 → $6.73
Current: $1.24
Upside: n/a
Oxford Biomedica plc
Sep 24, 2024
Maintained: Hold
Price Target: 250p → 380p
Current: 632p
Upside: n/a
Uniphar plc
Sep 4, 2024
Reiterated: Buy
Price Target: 310p
Current: 387p
Upside: n/a
Avacta Group Plc
Jun 19, 2024
Initiated Coverage: Hold
Price Target: 40p
Current: 70p
Upside: n/a
NIOX Group Plc
May 3, 2024
Initiated Coverage: Hold
Price Target: 250p
Current: 60p
Upside: n/a
Creo Medical Group PLC
May 3, 2024
Maintained: Buy
Price Target: 80p
Current: 14p
Upside: n/a
May 3, 2024
Initiated Coverage: Buy
Price Target: 100p
Current: 66p
Upside: n/a